- We will send in 10–14 business days.
/images/books/13170346/9783638727211.jpg)
- Author: Juliane Kuballa
- Publisher: GRIN Verlag
- Year: 2007
- Pages: 72
- ISBN-10: 3638727211
- ISBN-13: 9783638727211
- Format: 14.8 x 21 x 0.4 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Reviews
Description
Seminar paper from the year 2006 in the subject Business economics - Investment and Finance, grade: 80, Northumbria University (Newcastle Northumbria University), language: English, abstract: In the first part, this academic assignment provides general information about motives for international acquisitions. Moreover, it discusses whether foreign exchange markets and stock markets can be said to be efficient. The second part critically analyses the Merger of Sanofi-Synthélabo and Aventis by examining the following aspects: - market position of each company prior to the merger - motives for the proposed merger - attack and defence tactics applied by Sanofi-Synthélabo and Aventis - methods used to finance the merger - share price movements immediately before during and after the proposed take-over (commenting on the benefits to shareholders of each company) - company performance in the period following the take-over (reflecting on the initial take-over motives)
EXTRA 10 % discount with code: EXTRA
The promotion ends in 17d.17:49:14
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Juliane Kuballa
- Publisher: GRIN Verlag
- Year: 2007
- Pages: 72
- ISBN-10: 3638727211
- ISBN-13: 9783638727211
- Format: 14.8 x 21 x 0.4 cm, softcover
- Language: English English
Seminar paper from the year 2006 in the subject Business economics - Investment and Finance, grade: 80, Northumbria University (Newcastle Northumbria University), language: English, abstract: In the first part, this academic assignment provides general information about motives for international acquisitions. Moreover, it discusses whether foreign exchange markets and stock markets can be said to be efficient. The second part critically analyses the Merger of Sanofi-Synthélabo and Aventis by examining the following aspects: - market position of each company prior to the merger - motives for the proposed merger - attack and defence tactics applied by Sanofi-Synthélabo and Aventis - methods used to finance the merger - share price movements immediately before during and after the proposed take-over (commenting on the benefits to shareholders of each company) - company performance in the period following the take-over (reflecting on the initial take-over motives)
Reviews